# ELBA: Exemestane and Lapatinib in Advanced Breast Cancer

> **NCT01005641** · PHASE2 · WITHDRAWN · sponsor: **National Cancer Institute, Naples**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** exemestane
- **DRUG:** lapatinib

## Key facts

- **NCT ID:** NCT01005641
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-12
- **Primary completion:** 2011-10
- **Final completion:** 2012-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not started for administrative reasons
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005641, "ELBA: Exemestane and Lapatinib in Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01005641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*